Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Accepts FDA Opportunity for a Hearing on ...
Highlights faulty FDA review WASHINGTON, Jan. 27, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provides an update on the tradipitant ...
Vanda Pharmaceuticals Accepts FDA Opportunity for a Hearing on New Drug Application for ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provides an update on the tradipitant development program.
SouthFlorida Reporter5 天
GLP-1 Drugs Linked To Lower Dementia Risk, Higher Risk Of Kidney, Stomach Issues
A new study reports that GLP-1 medications may provide benefits to cognitive and behavioral health, including lowered ...
The Argus5 天
Crawley woman with gastroparesis left to fund private care
A woman living with a debilitating condition says she has been forced to spend nearly £40,000 on private healthcare after the NHS said they ...